Metropolitan Life Insurance Company (MetLife)’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-59,086
| Closed | -$4.05M | – | 333 |
|
|
2024
Q1 | $4.05M | Sell |
59,086
-514
| -0.9% | -$33K | 0.18% | 105 |
|
|
2023
Q4 | $3.45M | Sell |
59,600
-981
| -2% | -$52.4K | 0.16% | 116 |
|
|
2023
Q3 | $3.2M | Sell |
60,581
-2,073
| -3% | -$109K | 0.17% | 109 |
|
|
2023
Q2 | $3.39M | Sell |
62,654
-1,410
| -2% | -$73.6K | 0.16% | 110 |
|
|
2023
Q1 | $3.21M | Sell |
64,064
-16,997
| -21% | -$801K | 0.16% | 114 |
|
|
2022
Q4 | $3.75M | Sell |
81,061
-4,171
| -5% | -$181K | 0.17% | 119 |
|
|
2022
Q3 | $3.3M | Sell |
85,232
-873
| -1% | -$35K | 0.16% | 127 |
|
|
2022
Q2 | $3.21M | Sell |
86,105
-1,833
| -2% | -$74.6K | 0.14% | 143 |
|
|
2022
Q1 | $3.89M | Sell |
87,938
-74,837
| -46% | -$3.24M | 0.14% | 141 |
|
|
2021
Q4 | $6.91M | Sell |
162,775
-4,611
| -3% | -$194K | 0.09% | 170 |
|
|
2021
Q3 | $7.26M | Sell |
167,386
-5,386
| -3% | -$238K | 0.11% | 153 |
|
|
2021
Q2 | $7.39M | Sell |
172,772
-2,549
| -1% | -$107K | 0.1% | 150 |
|
|
2021
Q1 | $6.78M | Sell |
175,321
-10,245
| -6% | -$388K | 0.1% | 159 |
|
|
2020
Q4 | $6.67M | Sell |
185,566
-7,145
| -4% | -$258K | 0.1% | 160 |
|
|
2020
Q3 | $7.36M | Sell |
192,711
-7,751
| -4% | -$299K | 0.12% | 136 |
|
|
2020
Q2 | $7.04M | Sell |
200,462
-71,741
| -26% | -$2.58M | 0.12% | 142 |
|
|
2020
Q1 | $8.88M | Sell |
272,203
-3,876
| -1% | -$151K | 0.18% | 103 |
|
|
2019
Q4 | $12.5M | Buy |
276,079
+248
| +0.1% | +$10.4K | 0.2% | 92 |
|
|
2019
Q3 | $11.2M | Buy |
275,831
+17,510
| +7% | +$742K | 0.19% | 94 |
|
|
2019
Q2 | $11.1M | Buy |
258,321
+15,084
| +6% | +$580K | 0.19% | 90 |
|
|
2019
Q1 | $9.34M | Sell |
243,237
-9,442
| -4% | -$361K | 0.17% | 100 |
|
|
2018
Q4 | $8.93M | Sell |
252,679
-992
| -0.4% | -$36K | 0.18% | 95 |
|
|
2018
Q3 | $9.77M | Sell |
253,671
-6,185
| -2% | -$216K | 0.17% | 103 |
|
|
2018
Q2 | $8.5M | Sell |
259,856
-13,105
| -5% | -$395K | 0.14% | 133 |
|
|
2018
Q1 | $7.46M | Buy |
272,961
+1,443
| +0.5% | +$39.2K | 0.11% | 149 |
|
|
2017
Q4 | $6.73M | Sell |
271,518
-437,930
| -62% | -$12.1M | 0.09% | 171 |
|
|
2017
Q3 | $20.7M | Sell |
709,448
-7,806
| -1% | -$216K | 0.13% | 139 |
|
|
2017
Q2 | $19.9M | Sell |
717,254
-7,922
| -1% | -$210K | 0.14% | 137 |
|
|
2017
Q1 | $18M | Sell |
725,176
-9,131
| -1% | -$222K | 0.13% | 148 |
|
|
2016
Q4 | $15.9M | Sell |
734,307
-20,086
| -3% | -$438K | 0.11% | 166 |
|
|
2016
Q3 | $18M | Sell |
754,393
-7,475
| -1% | -$178K | 0.13% | 145 |
|
|
2016
Q2 | $17.8M | Buy |
761,868
+54,325
| +8% | +$1.18M | 0.13% | 143 |
|
|
2016
Q1 | $13.3M | Sell |
707,543
-8,725
| -1% | -$153K | 0.1% | 188 |
|
|
2015
Q4 | $13.2M | Sell |
716,268
-18,116
| -2% | -$325K | 0.1% | 190 |
|
|
2015
Q3 | $12.1M | Sell |
734,384
-11,661
| -2% | -$199K | 0.09% | 217 |
|
|
2015
Q2 | $13.2M | Buy |
746,045
+2,444
| +0.3% | +$43.7K | 0.09% | 208 |
|
|
2015
Q1 | $13.2M | Sell |
743,601
-7,593
| -1% | -$120K | 0.1% | 213 |
|
|
2014
Q4 | $9.95M | Buy |
751,194
+5,678
| +0.8% | +$72.6K | 0.07% | 279 |
|
|
2014
Q3 | $8.8M | Sell |
745,516
-9,607
| -1% | -$121K | 0.06% | 298 |
|
|
2014
Q2 | $9.64M | Sell |
755,123
-33,313
| -4% | -$433K | 0.07% | 288 |
|
|
2014
Q1 | $10.7M | Sell |
788,436
-19,316
| -2% | -$254K | 0.07% | 267 |
|
|
2013
Q4 | $9.71M | Sell |
807,752
-32,739
| -4% | -$387K | 0.07% | 294 |
|
|
2013
Q3 | $9.87M | Sell |
840,491
-8,162
| -1% | -$88.3K | 0.08% | 267 |
|
|
2013
Q2 | $7.87M | Buy |
+848,653
| New | +$7.2M | 0.06% | 321 |
|
Other funds holding BSX
Metropolitan Life Insurance Company (MetLife)'s BSX Position: Q2 2024 in Review
Metropolitan Life Insurance Company (MetLife) sold out of Boston Scientific (BSX) in Q2 2024, closing a stake of 59,086 shares — an estimated $4.05M sold.
Metropolitan Life Insurance Company (MetLife) first reported a position in BSX in Q2 2013 and held it in 44 quarters. The position peaked at $20.7M in Q3 2017. 1,318 funds tracked by Wall St. Rank hold BSX as of Q2 2024.
- Metropolitan Life Insurance Company (MetLife) reported no remaining Boston Scientific position as of Q2 2024 after selling out during the quarter.
- Metropolitan Life Insurance Company (MetLife) sold 59,086 Boston Scientific shares in Q2 2024, an estimated $4.05M.
- Metropolitan Life Insurance Company (MetLife) first reported a position in Boston Scientific in Q2 2013 and held it in 44 quarters.
- Metropolitan Life Insurance Company (MetLife)'s Boston Scientific position peaked at $20.7M in Q3 2017.
- 1,318 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2024.
Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2024, filed 13 Aug 2024.